Exelixis | Rentekostnader



Interest Expense On Debt Endring Dato
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Amgen USD 723M 24M 2025-03
AstraZeneca 429M 28M 2024-12
Bayer 703M 61M 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Cytokinetics USD 22.59M 296K 2024-12
Eisai 777M 167M 2024-12
Eli Lilly USD 243.7M 19M 2025-03
Exelixis 23.4M 3.9M 2023-09
Genmab DKK 2.68B 1.98B 2024-12
Glaxosmithkline 178.05M 24.73M 2024-12
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
MacroGenics USD -24000 24K 2024-12
Merck USD 328M 2M 2024-12
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Sanofi 66.11M 20.67M 2024-12
Takeda 31.6B 36.86B 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Xencor -39359000 40.15M 2024-12



Exelixis Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.